OGN
What one share of Organon & holds
Pharmaceutical Preparations
Organon & Co. (“Organon,” the “Company,” “we,” “our,” or “us”) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day.
Organon &’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $23.49 |
|---|---|
| Profit | $0.80 |
| Capex (buildings and equipment) | $0.65 |
| Free cash flow | $2.17 |
| Dividends | $0.08 |
| Cash and investments | $4.31 |
| Debt | $32.29 |
| Book value | $3.83 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $30.68 | $12.69 | $0.36 | $11.55 | — | $27.75 |
| 2020 | $25.77 | $8.52 | $1.01 | $8.00 | — | $21.64 |
| 2021 | $24.80 | $5.31 | $0.76 | $7.74 | $0.56 | −$5.95 |
| 2022 | $24.20 | $3.59 | $0.77 | $2.59 | $1.12 | −$3.51 |
| 2023 | $24.44 | $3.99 | $0.98 | $2.14 | $1.12 | −$0.27 |
| 2024 | $24.71 | $3.33 | $0.68 | $2.95 | $1.12 | $1.83 |
| 2025 | $23.84 | $0.72 | $0.62 | $2.06 | $0.34 | $2.89 |